| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.009 | 0.9 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.9 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | -0.025 | 0.9 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.025 | 0.9 |